2- (((amino(imino)methyl)amino)carbonyl)- 1- methyl- 4- trifluoromethyl- 1H- indol- 7- yl- hydrogen- sulfate monohydrate

Subscribe to Selected New Research on 2-(((amino(imino)methyl)amino)carbonyl)-1-methyl-4-trifluoromethyl-1H-indol-7-yl-hydrogen-sulfate monohydrate

2 relevant articles (1 outcomes, 0 trials/studies) found for this Bio-Agent

Description: a potent Na+/H+exchange inhibitor

Also Known As:

SM-197378

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

2-Ring Heterocyclic Compounds

Indoles: 69

2-(((amino(imino)methyl)amino)carbonyl)-1-methyl-4-trifluoromethyl-1H-indol-7-yl-hydrogen-sulfate monohydrate: 2

Experts

1.	Kitano, Masafumi: 1 article (10/2005)
2.	Mori, Masaya: 1 article (10/2005)
3.	Matsui, Kazuki: 1 article (10/2005)
4.	Yamada, Kazuto: 1 article (10/2005)
5.	Yamamoto, Setsuko: 1 article (10/2005)
6.	Ogawa, Shoji: 1 article (10/2005)
7.	Ohashi, Naohito: 1 article (10/2005)

Related Diseases

1.	Ischemia 10/03/2005 - "With 90 min of ischemia, the anti-necrotic effect of SM-197378 was superior to that of ischemic preconditioning." 10/03/2005 - "Intravenous administration of SM-197378 before ischemia reduced the infarct size by approximately 30-50% in a dose-dependent manner" 10/25/2004 - "The recovery of left ventricular developed pressure (LVDP) from ischemia by reperfusion was 39.0% in the control, while in the hearts pretreated with SM-198110 or SM-197378 (10(-7) M), it was about 100%" 10/25/2004 - "The protective effects of the Na+-H+ exchange (NHE) inhibitors SM-198110 (2-[[(aminoiminomethyl) amino] carbonyl]-4-chloro-1H-indole-1-propanesulfonic acid monohydrate) and SM-197378 (N-(aminoiminomethyl)-1-methyl-7-(sulfooxy)-4-(trifluoromethyl)-1H-indole-2-carboxamide monohydrate) were investigated in perfused Langendorff guinea-pig hearts subjected to ischemia (40 min) and reperfusion (40 min)" 10/03/2005 - "With 30 and 60 min of ischemia, the anti-necrotic effects of SM-197378 and ischemic preconditioning were similar and superior to that of nicorandil" Get all the results and reference details, order at left...
2.	Myocardial Ischemia (Ischemic Heart Diseases) 10/03/2005 - "The effects of SM-197378, 2-[[[amino(imino)methyl]amino]carbonyl]-1-methyl-4-trifluoromethyl-1H-indol-7-yl=hydrogen=sulfate monohydrate, a novel potent Na+/H+exchange inhibitor, on heart injury were studied using a rabbit model involving 30 min of myocardial ischemia and 5 h of reperfusion" Get all the results and reference details, order at left...
3.	Myocardial Infarction 10/03/2005 - "Reduction of myocardial infarct size by SM-197378, a novel Na+/H+ exchange inhibitor, in rabbits." Get all the results and reference details, order at left...
4.	Heart Injuries 10/03/2005 - "The effects of SM-197378, 2-[[[amino(imino)methyl]amino]carbonyl]-1-methyl-4-trifluoromethyl-1H-indol-7-yl=hydrogen=sulfate monohydrate, a novel potent Na+/H+exchange inhibitor, on heart injury were studied using a rabbit model involving 30 min of myocardial ischemia and 5 h of reperfusion" Get all the results and reference details, order at left...
4 Diseases and 2 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	indole
2.	Nicorandil (SG 75)
3.	Hydrogen
3 Drugs and Important Bio-Agents and 2 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>